{
  "id": "601ec2d61cb411341a000062",
  "type": "factoid",
  "question": "What disease is associate with defects in both the KDM6A (lysine specific demethylase 6A) and KMT2D (lysine methyltransferase 2D)",
  "ideal_answer": "Over the last 20 years, mutations in five key COMPASS complex genes have been linked to three human congenital syndromes: Kabuki syndrome (type 1 [KMT2D] and 2 [KDM6A]",
  "documents": [
    "http://www.ncbi.nlm.nih.gov/pubmed/27028180",
    "http://www.ncbi.nlm.nih.gov/pubmed/29073101",
    "http://www.ncbi.nlm.nih.gov/pubmed/31924266",
    "http://www.ncbi.nlm.nih.gov/pubmed/30509212",
    "http://www.ncbi.nlm.nih.gov/pubmed/24838796",
    "http://www.ncbi.nlm.nih.gov/pubmed/29725259",
    "http://www.ncbi.nlm.nih.gov/pubmed/31282990",
    "http://www.ncbi.nlm.nih.gov/pubmed/31935506",
    "http://www.ncbi.nlm.nih.gov/pubmed/32817139",
    "http://www.ncbi.nlm.nih.gov/pubmed/25934606",
    "http://www.ncbi.nlm.nih.gov/pubmed/31740281",
    "http://www.ncbi.nlm.nih.gov/pubmed/31883305"
  ],
  "snippets": [
    {
      "text": " Over the last 20 years, mutations in five key COMPASS complex genes have been linked to three human congenital syndromes: Kabuki syndrome (type 1 [KMT2D] and 2 [KDM6A]), ",
      "document": "http://www.ncbi.nlm.nih.gov/pubmed/31924266",
      "beginSection": "abstract",
      "endSection": "abstract"
    },
    {
      "text": "Heterozygous, de novo dominant mutations in either KMT2D or KDM6A underlie KS. ",
      "document": "http://www.ncbi.nlm.nih.gov/pubmed/31883305",
      "beginSection": "abstract",
      "endSection": "abstract"
    },
    {
      "text": "ll 25 patients with KS carried de novo, likely pathogenic or pathogenic variants in either KMT2D or KDM6A. ",
      "document": "http://www.ncbi.nlm.nih.gov/pubmed/31883305",
      "beginSection": "abstract",
      "endSection": "abstract"
    },
    {
      "text": "abuki syndrome is a rare genetic disorder, caused by mutation in the KMT2D or KDM6A genes, which affects several organs in the majority of patients, among which are the eyes.",
      "document": "http://www.ncbi.nlm.nih.gov/pubmed/31740281",
      "beginSection": "abstract",
      "endSection": "abstract"
    },
    {
      "text": "Identification of KMT2D and KDM6A variants by targeted sequencing from patients with Kabuki syndrome and other congenital disorders",
      "document": "http://www.ncbi.nlm.nih.gov/pubmed/31935506",
      "beginSection": "title",
      "endSection": "title"
    },
    {
      "text": "Studies have determined that pathogenic variants of the lysine-specific methyltransferase 2D (KMT2D) and lysine-specific demethylase 6A (KDM6A) genes are the major causes of KS",
      "document": "http://www.ncbi.nlm.nih.gov/pubmed/31935506",
      "beginSection": "abstract",
      "endSection": "abstract"
    },
    {
      "text": "Overall, we uncovered 11 novel variants - nine in KMT2D and two in KDM6A. Seven of the novel variants (all KMT2D) were likely causative of the KS phenotype.",
      "document": "http://www.ncbi.nlm.nih.gov/pubmed/31935506",
      "beginSection": "abstract",
      "endSection": "abstract"
    },
    {
      "text": "Two genes have been shown to be mutated in patients with KS: lysine (K)-specific demethylase 6A (KDM6A) and lysine (K)-specific methyltransferase 2D (KMT2D, formerly MLL2).",
      "document": "http://www.ncbi.nlm.nih.gov/pubmed/30509212",
      "beginSection": "abstract",
      "endSection": "abstract"
    },
    {
      "text": "Finally, understanding the interactions between KMT2D and its target genes could unravel other candidate genes for hitherto unexplained Kabuki syndrome cases.",
      "document": "http://www.ncbi.nlm.nih.gov/pubmed/25934606",
      "beginSection": "abstract",
      "endSection": "abstract"
    },
    {
      "text": "Kabuki syndrome is caused by mutations or deletions of lysine (K)-specific methyltransferase 2D (KMT2D) and lysine-specific methylase 6A (KDM6A).",
      "document": "http://www.ncbi.nlm.nih.gov/pubmed/24838796",
      "beginSection": "abstract",
      "endSection": "abstract"
    },
    {
      "text": "Despite more than 350 documented cases, the oro-dental spectrum associated with kabuki syndrome and expression of KMT2D (histone-lysine N-methyltransferase 2D) or KDM6A (lysine-specific demethylase 6A) genes in tooth development have not been well defined. Here, we report seven unrelated Thai patients with ",
      "document": "http://www.ncbi.nlm.nih.gov/pubmed/29725259",
      "beginSection": "abstract",
      "endSection": "abstract"
    },
    {
      "text": "pite more than 350 documented cases, the oro-dental spectrum associated with kabuki syndrome and expression of KMT2D (histone-lysine N-methyltransferase 2D) or KDM6A (lysine-specific demethylase 6A) genes in tooth development have not been well",
      "document": "http://www.ncbi.nlm.nih.gov/pubmed/29725259",
      "beginSection": "abstract",
      "endSection": "abstract"
    },
    {
      "text": "Exonic deletions, disrupting the lysine (K)-specific demethylase 6A (KDM6A) gene have been demonstrated as rare cause of KS.",
      "document": "http://www.ncbi.nlm.nih.gov/pubmed/27028180",
      "beginSection": "abstract",
      "endSection": "abstract"
    },
    {
      "text": "Identification of KMT2D and KDM6A variants by targeted sequencing from patients with Kabuki syndrome and other congenital disorders.",
      "document": "http://www.ncbi.nlm.nih.gov/pubmed/31935506",
      "beginSection": "title",
      "endSection": "title"
    },
    {
      "text": "Despite more than 350 documented cases, the oro-dental spectrum associated with kabuki syndrome and expression of KMT2D (histone-lysine N-methyltransferase 2D) or KDM6A (lysine-specific demethylase 6A) genes in tooth development have not been well defined.",
      "document": "http://www.ncbi.nlm.nih.gov/pubmed/29725259",
      "beginSection": "abstract",
      "endSection": "abstract"
    },
    {
      "text": "Heterozygous germline mutations in the KMT2D gene are known to cause Kabuki syndrome (OMIM 147920), a developmental multisystem disorder.",
      "document": "http://www.ncbi.nlm.nih.gov/pubmed/31282990",
      "beginSection": "abstract",
      "endSection": "abstract"
    },
    {
      "text": "Mutations of KDM6A cause Kabuki syndrome.",
      "document": "http://www.ncbi.nlm.nih.gov/pubmed/32817139",
      "beginSection": "abstract",
      "endSection": "abstract"
    },
    {
      "text": "Kabuki syndrome, a congenital craniofacial disorder, manifests from mutations in an X-linked histone H3 lysine 27 demethylase (UTX/KDM6A) or a H3 lysine 4 methylase (KMT2D).",
      "document": "http://www.ncbi.nlm.nih.gov/pubmed/29073101",
      "beginSection": "abstract",
      "endSection": "abstract"
    }
  ],
  "concepts": [],
  "exact_answer": "Kabuki syndrome, KS"
}